Transplante de célula-tronco hematopoética para síndrome mielodisplásica

Tabak, Daniel G; Pereira, Simone C. M; Nogueira, Marta C.
Rev. bras. hematol. hemoter ; 32(supl.1): 66-70, maio 2010. ilus
Artigo em Português | LILACS | ID: lil-554157

Documentos relacionados

  1. Treatment strategies for myelodysplastic syndrome in 2021.
  2. Allogeneic Stem Cell Transplantation for Patients with Lower-Risk Myelodysplastic Syndrome.
  3. Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management.